-+ 0.00%
-+ 0.00%
-+ 0.00%

SCHOLAR ROCK RECEIVES FDA FAST TRACK DESIGNATION FOR APITEGROMAB FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD) PROGRAM AS PARTICIPANT DOSING COMMENCES IN PHASE 2 FORGE TRIAL

Reuters·09/02/2026 12:00:02

Please log in to view news